Thymulin
A zinc-dependent thymic nonapeptide that drives T-lymphocyte differentiation and helps rebalance the aging, inflammation-prone immune system.
Thymulin (facteur thymique serique; FTS) is an endogenous zinc-dependent nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) produced exclusively by thymic epithelial cells, identified by Dardenne and Bach in the 1970s as the circulating thymic hormone that promotes peripheral T-cell differentiation and maturation. Its biological activity requires chelation of a zinc ion to form the active zinc-thymulin complex, and circulating levels decline measurably with age and zinc deficiency. It is studied primarily in preclinical models for immune senescence and anti-inflammatory applications; no human randomized controlled trials have been published.
Class
Endogenous zinc-dependent nonapeptide (thymic hormone)
Routes
Subcutaneous
Category
Immune & Mitochondrial
Researched benefits
What it's studied for
Immune modulation
Acts on the neuroendocrine-immune axis to help rebalance immune function; the zinc-thymulin complex modulates cytokine output and interacts with pituitary hormones. Levels decline with age, and exogenous administration has partially restored immune function in aged animal models.
T-cell maturation
Binds receptors on immature T-lymphocytes to promote their differentiation and maturation in the peripheral immune system, the core physiological role that defines thymulin as a thymic hormone.
NK cell support
Reported to enhance natural killer cell activity as part of its broader immunomodulatory profile, contributing to innate immune surveillance in preclinical contexts.
Anti-inflammatory activity
In a mouse colitis model, daily thymulin reduced tissue inflammation and shifted cytokine balance, lowering interferon-gamma and proinflammatory interleukins while raising anti-inflammatory IL-10. Reviews also describe anti-inflammatory and analgesic actions in the brain.
Mechanism
How it works
Thymulin is a nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) secreted exclusively by thymic epithelial cells. Its defining feature is zinc dependency: the peptide must chelate a zinc ion to form the biologically active zinc-thymulin complex. Without adequate zinc, circulating thymulin exists in an inactive form, which is why both aging and dietary zinc deficiency measurably reduce active thymulin levels.
The active complex binds to receptors on immature T-lymphocytes, driving their differentiation and maturation in the peripheral immune system. This positions thymulin as a key mediator of thymic-dependent immunity and a marker of thymic function that falls with immune senescence.
Beyond direct T-cell effects, thymulin regulates cytokine balance and modulates the neuroendocrine-immune axis through bidirectional interactions with pituitary hormones. In inflammatory settings it shifts the cytokine milieu toward resolution, decreasing interferon-gamma and proinflammatory interleukins while increasing anti-inflammatory IL-10.
Preclinical work in aged animal models shows that exogenous thymulin can partially restore declining immune function, and gene-therapy studies suggest thymulin can be expressed long-term without provoking immune destruction of transduced cells. The evidence base remains exclusively preclinical, and the zinc-dependency of the active form is an important limitation for any discussion of supplementation.
Dosing protocols
Dosing & administration
Dosing reflects protocols reported in research and community literature for educational purposes. It is not medical advice or a recommendation. Most peptides here are not approved for human use.
Preclinical (animal models)
- Dose
- Not established for humans
- Frequency
- Daily in study models
- Timing
- Not specified
- Duration
- Not specified
- Route
- Subcutaneous
Published anti-inflammatory data come from daily subcutaneous administration in mice (DSS colitis model). No validated human dose exists; specific mcg/mg regimens were not reported in the source literature.
- No human randomized controlled trials have been published, and no standardized human dosing protocol has been established.
- Biological activity depends on zinc; adequate zinc status is a prerequisite for thymulin to form its active complex.
- The subcutaneous route is the one reflected in available research and provider listings.
Evidence
Research & clinical studies (2)
The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin
Summarizes evidence that thymulin (FTS), a zinc-dependent thymic nonapeptide, regulates intrathymic and extrathymic T-cell differentiation, has anti-inflammatory and analgesic properties in the brain, and shows promise in adenoviral gene therapy models for sustained expression without immune destruction of transduced cells.
PMID 19236333In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice
Daily subcutaneous thymulin significantly reduced lethality, weight loss, and histological inflammation in chronic DSS-induced colitis, with decreased interferon-gamma and proinflammatory interleukins and increased IL-10 production in lamina propria cells.
PMID 17499195Safety
Side effects & considerations
Contraindications & cautions
- Active or history of cancer
- Pregnancy or nursing
Generally considered lower risk in research contexts, but individual response varies and the evidence base is exclusively preclinical. No specific adverse effects were catalogued in the source literature; review all considerations and consult a qualified healthcare professional before use.
FAQ
Thymulin — common questions
What is Thymulin?
Thymulin (facteur thymique serique; FTS) is an endogenous zinc-dependent nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) produced exclusively by thymic epithelial cells. Identified by Dardenne and Bach in the 1970s, it is the circulating thymic hormone responsible for promoting T-cell differentiation and maturation in the peripheral immune system.
Why does Thymulin need zinc?
Thymulin only becomes biologically active when it chelates a zinc ion to form the zinc-thymulin complex. Without adequate zinc, the peptide remains inactive, which is why both aging and zinc deficiency lower measured active thymulin levels.
What is Thymulin primarily studied for?
Its main research areas are immune modulation, T-cell maturation, natural killer cell support, and anti-inflammatory activity, largely in the context of age-related immune decline (immune senescence).
What does the research show?
A 2009 review describes thymulin regulating T-cell differentiation with anti-inflammatory and analgesic actions in the brain, and a 2007 mouse study found daily subcutaneous thymulin reduced inflammation in chronic colitis while shifting cytokines toward an anti-inflammatory profile. Evidence remains preclinical, with no published human RCTs.
Is Thymulin approved by the FDA?
No. Thymulin has not been evaluated by the FDA and has no approved therapeutic indication in any major jurisdiction. It is a research-only compound.
What are the safety considerations?
Thymulin is generally considered lower risk in research contexts, but reported contraindications include active or prior cancer and pregnancy or nursing. Because human data are limited, consult a qualified healthcare professional before any use.
